SEC Form 4 · accession 0001179110-15-008470
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Ortenzio
Officer — Exec. Chairman and Co-Founder · Director
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 20, 2015 | S | 250,000 | $16.22 | D | 5,788,153 | D | |
| Common StockF3 | May 21, 2015 | S | 250,000 | $16.45 | D | 5,538,153 | D | |
| Common StockF5,F6 | May 20, 2015 | S | 165,200 | $16.16 | D | 2,750,000 | I | By the Rocco A. Ortenzio Descendants Trust |
| Common StockF4 | holding | — | — | — | 1,300,000 | I | By the Robert A. Ortenzio Descendants Trust | |
| Common StockF4 | holding | — | — | — | 1,180,000 | I | By the Robert A. Ortenzio April 2014 GRAT | |
| Common StockF4 | holding | — | — | — | 800,000 | I | By The Robert A. Ortenzio May 2015 GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert Ortenzio on August 27, 2014.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote, footnote (3) and footnote (5) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.20 to $16.72, inclusive.
- F4These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by The Rocco A. Ortenzio Descendants Trust on March 19, 2014.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive.
- F6The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.